You are here

  • Home
  • Archive
  • Volume 7, Issue 8
  • Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

Article metrics

Article menu

Download PDFPDF

XML
Oncology
Research
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

 

Online download statistics by month:

Online download statistics by month: August 2017 to June 2022

AbstractFullPdf
Aug 2017598596184
Sep 2017464464184
Oct 201719819580
Nov 201712412350
Dec 201712111533
Jan 201811311343
Feb 201820118664
Mar 201816716453
Apr 201834036144
May 201837239671
Jun 201825225159
Jul 201826426491
Aug 201837038063
Sep 201837837864
Oct 201857057089
Nov 201839239253
Dec 201835835646
Jan 201950750662
Feb 201937837957
Mar 201951951975
Apr 201987587049
May 201952552840
Jun 201951151036
Jul 201935035031
Aug 201929029068
Sep 2019228228107
Oct 2019356356144
Nov 201928028090
Dec 201924224237
Jan 202034834852
Feb 202040140048
Mar 202040740730
Apr 202010010029
May 202012112035
Jun 202013813914
Jul 202014814238
Aug 202015214826
Sep 202024823537
Oct 202028927326
Nov 202028527238
Dec 202022021730
Jan 202122021128
Feb 202119619241
Mar 202118317638
Apr 202114214030
May 202110310121
Jun 2021979221
Jul 20211039718
Aug 202111211421
Sep 202111710930
Oct 202111310240
Nov 202112911749
Dec 202111311525
Jan 202214615839
Feb 202217318229
Mar 202216316818
Apr 202218618128
May 202210210429
Jun 202212813122
Total15726156532997